Format

Send to

Choose Destination
Europace. 2005 Sep;7(5):492-9.

Anticoagulation in atrial fibrillation and flutter.

Author information

1
Department of Clinical Electrophysiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands. m.f.scholten@erasmusmc.nl

Abstract

Atrial fibrillation and atrial flutter are important risk factors for stroke. Based on a literature search, pathogenesis of thromboembolism, risk assessment in patients, efficacy of anticoagulation therapy and its alternatives are discussed. Special emphasis is put on issues like paroxysmal atrial fibrillation, atrial flutter and anticoagulation surrounding catheter ablation and cardioversion. A strategy for anticoagulation around the time of pulmonary vein ablation is suggested.

PMID:
16087116
DOI:
10.1016/j.eupc.2005.05.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center